Machine (ASR) transcript of https://www.youtube.com/watch?v=xa87N2XaOp4 | source_id yt_xa87N2XaOp4 | audio file audio/xa87N2XaOp4__Cannabis_Science_Inc_with_CEO_Robert_Melamede_PhD.m4a sha256 a478d97162753d83e1f78875c971a910318cf947c39816889e13eae9723fee58 | manus-speech-to-text (Whisper-family ASR), segment granularity | generated 2026-11-21T16:53:28+00:00 | NOT human-verified [00:00:00] We're here with Dr. Robert Melamed, and I was wondering if you could tell us a little [00:00:04] bit about what you're involved in. [00:00:05] All right. [00:00:06] Well, I'm a professor at the University of Colorado at Colorado Springs, where formerly [00:00:10] I was chairman for a few years. [00:00:13] And now, in addition, I'm involved in creating a new company, publicly traded company, Cannabis [00:00:19] Science. [00:00:20] We're on the NASDAQ, and we're a fully reporting bulletin board company. [00:00:24] And our goal is to get cannabis-based medicines through the FDA, so that they'll be available [00:00:30] to anybody who needs them in any state in the union, and to have it covered by health [00:00:35] care. [00:00:36] It only seems appropriate that, after all these years of the government tormenting people, [00:00:41] that now they should be actually helping us to use cannabis. [00:00:45] I see. [00:00:46] Well, what kind of conditions would your company be able to benefit? [00:00:50] Well, right now, we're targeting, really, PTSD and chronic pain, because being in Colorado [00:00:55] Springs, which is a military town, we see all the time soldiers and other military personnel [00:01:02] who are really suffering from the lack of cannabis. [00:01:06] Currently, in my opinion, the medical policies that have been implemented to treat people [00:01:12] with post-traumatic stress, and so often the result of the various injuries that they have, [00:01:19] are literally the cause for the fact that there are more soldiers dying from suicide [00:01:25] than there are from the wars in Afghanistan and Iraq. [00:01:28] And what I'm really saying here is that people who have chronic pain should not be using [00:01:34] narcotics, or no more narcotics than they will need after they've been using cannabis. [00:01:41] Cannabis really is the ideal medicine for chronic pain. [00:01:46] And if it's not sufficient, then you supplement with narcotics. [00:01:49] It turns out that the simultaneous use of narcotics with cannabis, the cannabis reduces [00:01:55] the amount of narcotics that are necessary, depending on the narcotic being used, somewhere [00:01:59] between four and 25-fold. [00:02:02] And it also seems to reduce the propensity to develop a tolerance to the pain-relieving [00:02:10] effects. [00:02:11] Well, how does cannabis work well with narcotics? [00:02:15] Well, it's a complicated circuitry that's not all 100% clear. [00:02:20] There is overlap between the biochemistry of the system. [00:02:24] Some of the receptors seem to have crosstalk in them. [00:02:28] But cannabis itself directly impacts on our sensation, the acquisition of pain, the transmission [00:02:35] of pain, and then the perception of pain in our minds. [00:02:39] And at all of those levels, there's a cannabinoid involvement that can turn down, essentially, [00:02:46] the pain effects and the perception of pain. [00:02:49] So it's a very important modulator. [00:02:52] That's part of what it's evolved to do. [00:02:55] And obviously, if you have an acute injury, you get your arm blown off, immediately you [00:03:01] want narcotics. [00:03:02] There's just no question about that. [00:03:05] But when you're dealing with a lifetime, why put somebody on a drug that's addictive, that [00:03:11] tends to be depressing? [00:03:14] There's a holistic view to everything. [00:03:16] And that tends to be how I look at the world. [00:03:19] I try to understand what's going on from this big picture so that we can start to manipulate [00:03:26] to some degree and become, in a symbiotic manner, part of what's going on, rather than [00:03:33] fighting the flow. [00:03:35] But you also want to be able to direct it to some extent. [00:03:39] So the cannabinoid system within us is very much involved in allowing us to adapt to change [00:03:46] and to promoting creativity, which is what then allows us to create new channels to shift [00:03:52] the way things are flowing. [00:03:54] And what I'm trying to do with Cannabis Science, which is a publicly traded company, traded [00:04:00] on the NASDAQ bulletin board, a fully reporting company, symbol CBIS, what we're trying to [00:04:05] do is create a new paradigm, essentially, for capitalism. [00:04:09] Because capitalism is really very parallel with evolution, in that you have a selection [00:04:15] of the fittest. [00:04:17] But the problem with capitalism, as I see it, is that the way it's being driven by greed [00:04:23] and selfishness, by essentially the wrong kind of mindset for the individual who's been [00:04:27] successful up to this point, is inappropriate for the future. [00:04:32] I mean, it's been maybe useful to really drive things in terms of our technological developments [00:04:39] and a variety of other things. [00:04:41] But in order to have a world community that's sustainable, we have to shift away from greed [00:04:47] and use the same motivating principles, though, in terms of selection of the fittest, in order [00:04:54] to move into a sustainable future. [00:04:57] So what we're trying to do with Cannabis Science is, on the one hand, provide value to investors, [00:05:03] but I think even more importantly is to use the company as a tool for change. [00:05:08] Because when people invest in us, what we're trying to do is get medical marijuana extracts, [00:05:15] plant extracts, through the FDA, in particular to treat PTSD and chronic pain in veterans, [00:05:21] because these people are literally dying. [00:05:25] They're dying from suicide at a more rapid rate right now than they're dying from the [00:05:30] Afghanistan and Iraqi wars. [00:05:32] So that tells you there's a fundamental problem here. [00:05:36] And our endocannabinoid system really shows us the way, because what our endocannabinoid [00:05:42] system does with respect to memory is, again, you have to have this balance between remembering [00:05:49] and forgetting. [00:05:50] And forgetting is always a balance of opposing forces. [00:05:52] So if you imagine remembering all the unpleasant things in your life and having those dominate [00:05:57] your consciousness, you can see that there's a problem. [00:05:59] And it's your endocannabinoids that help you forget unpleasant memories. [00:06:04] So if you've been overstressed or genetically, biochemically limited in terms of your ability [00:06:10] to deal with stress, then you need to help supplement those helpful effects that the [00:06:17] cannabinoid system provides us with. [00:06:20] And the best way to do that in these conditions, really, is to supplement with phytocannabinoids, [00:06:25] the plant compounds that so uniquely interact with our endocannabinoid system, again, to [00:06:31] help protect neurons, to rewire neurons, to grow new neurons that allow us to change the [00:06:37] way we're thinking and to better adapt to those stressful circumstances. [00:06:43] So what we're trying to do with cannabis science, on the one hand, is provide investors [00:06:48] with the opportunity to invest in a company that's trying to promote this fundamental [00:06:53] change by allowing more cannabis to be entered into our human population. [00:07:00] Because that's what we need, really, now for mankind's survival, is we have to change the [00:07:05] way we think in a way consistent with harmony and creativity and solutions and optimism [00:07:12] and cooperativity, all the things that people who use cannabis knows it promotes. [00:07:19] But also in terms of these individuals that they individually can benefit. [00:07:26] So again, the model is to allow people to invest in that change, but furthermore, we're [00:07:32] going to be in order to actually have acquired dispensaries. [00:07:36] And what that's allowing us to do, then, is to have the people who are using marijuana, [00:07:43] by buying their medicine, they're also investing in the company's ability to travel through [00:07:49] the FDA and to spread the medicine so that everybody can go to a pharmacy in any state [00:07:55] and pick up cannabis extracts and have it covered by their health system, their healthcare [00:08:01] system. [00:08:02] That's one of the biggest problems with commercializing, and it's inevitable that this is going to [00:08:07] be a tremendous industry, but I guess the root quandary is making sure that compassion [00:08:15] stays in that equation. [00:08:17] Well, we are 100% in favor of legalization, but we know that even if it were legal today, [00:08:25] there's going to be a subset of the population who wants to go to the doctor, get a prescription, [00:08:31] go to a pharmacy, get the highest quality, standardized, regulated product, and have [00:08:38] it covered by healthcare. [00:08:40] So that's who we ultimately want to address, but in order to have that limited group available, [00:08:47] we want everybody else to be able to do what they want. [00:08:50] The idea of regulating growth of a plant that's an anti-aging drug that kills cancer is just [00:08:55] a little absurd to me, but nevertheless, that's the society we're in, and the way we're going [00:09:01] to change it is by having more cannabis in the society because of how it promotes open-mindedness [00:09:06] and the ability to change. [00:09:08] So there's a whole big feedback loop in here, and we're trying to have the company really [00:09:14] serve as this novel paradigm for a new way of being. [00:09:18] Well, Doctor, I'd like to thank you for being here with us today. [00:09:22] It's been my pleasure.